Genetic Diseases of the Kidney

Q&As with ASN Foundation Grant Recipients 2018

The following articles are brief Q&A sessions with American Society of Nephrology (ASN) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.


ASN Pre-Doctoral Fellowship Awardimages_pag_thumb.png

Amar J. Majmundar, MD, PhD - Jared J. Grantham Research Fellowship (2018)

Name: Amar J. Majmundar, MD, PhD

Institution: Boston Children's Hospital

Grant: Jared J. Grantham Research Fellowship (2018)

Project Title: Whole Exome Sequencing to Identify Novel Monogenic Causes of Nephrolithiasis
 

How would you sum up your research in one sentence?

Rebecca Hjorten, MD - Sharon Anderson Research Fellowship Award (2018)

Name: Rebecca Hjorten, MD

Institution: Cincinnati Children's Hospital Medical Center

Grant: Sharon Anderson Research Fellowship Award (2018)

Project Title: Modeling APOL1 Disease in Drosophila Melanogaster
 

How would you sum up your research in one sentence?

Otsuka’s JYNARQUE™ (tolvaptan) is the first treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) approved by FDA

"The progressive nature of ADPKD means that kidney function gets worse over time, eventually leading to end-stage renal disease. This progression happens more rapidly for some patients than others.” said Michal Mrug, M.D., Associate Professor at the University of Alabama at Birmingham and investigator on the REPRISE trial. “Today’s approval is great news for adults at risk of rapidly progressing ADPKD because by slowing the decline in kidney function, this therapy may give them more time before kidney transplant or dialysis.”

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

U.S. Opioid Crisis: July Special Section


The July issue of Kidney News features a special section on the US opioid epidemic and the correlation with kidney disease.

 

Interactive Map

Physician stress and burnout: The causes and potential solutions for nephrologists

At Kidney Week in New Orleans, I presented a session on the impact of growing stress and burnout in Nephrologists and how it might affect physician attitudes and behaviors toward patient care. The main point of my talk was to recognize how serious an issue physician dissatisfaction, stress, and burnout is, the causes and the barriers, and what can be done to help our physicians (and staff) better adjust to the pressures of today’s health care environment.


Let me explain.

Benjamin Freedman, PhD speaks about CRISPR and the future of treating polycystic kidney disease in recent study: "Organoid cystogenesis reveals a critical role of microenvironment in human PKD"

A recent study was published online in Nature Materials entitled “Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease” on October 2, 2017.

Please access the abstract and full report on the Nature website.

Congress Passes Omnibus Bill, Heads to White House - Approves $2 billion to NIH

On Wednesday, May 3rd, the House passed a bipartisan $1 trillion omnibus spending bill by a vote of 309-118, and the Senate passed the bill 79-18 on Thursday, May 4th.  The spending package avoided a government shutdown and funds the government at updated levels through the end of September.  

Open Payments Physician and Teaching Hospital Review and Dispute Period Ends Next Week

Physicians and teaching hospitals have until May 15, 2017 to review data reported by drug and medical device makers about them and, if necessary, dispute the payments before the data is made public on June 30, 2017.

Pages